Latest News
Warwick graduate invents revolutionary device for testing drugs
A scientist and University of Warwick gradute from Kazakhstan who works for Medherant Ltd - a spin-out of the University of Warwick which produces next-generation drug delivery patches - has invented a revolutionary device for testing transdermal drugs more quickly, efficiently and accurately.
Gold origin confirmed with first ever neutron star gravitational wave sighting
Gold’s origin in the Universe has finally been confirmed, after a gravitational wave source was seen and heard for the first time ever by an international collaboration of researchers, with astronomers at the University of Warwick playing a leading role.
Professor Celia Lury elected as Fellow of the Academy of Social Sciences
The Academy of Social Sciences has awarded a Fellowship to Professor Celia Lury, Director of the Centre for Interdisciplinary Methodologies (CIM) at the University of Warwick. Each year a number of Fellowships are awarded to recognise leading social scientists, who are judged on the excellence and impact of their work in using social science for public benefit.
One in five witness someone collapse who requires CPR but the majority do not act
An estimated one in five adults in the UK witness someone collapse who needs immediate CPR, yet the majority of people do not act, according to new research funded by the British Heart Foundation and conducted by Warwick Medical School.
Milestone hit in the construction of the National Automotive Innovation Centre
The National Automotive Innovation Centre, at the University of Warwick, saw a construction milestone hit, today, with the completion of the external grounds. WMG’s Professor Lord Bhattacharyya, Jaguar Land Rover’s Professor Dr Ralf Speth and TMETC’s John O’Connor, along with Leo Quinn, Balfour Beatty Group Chief Executive, and Rosie Drinkwater, University of Warwick ,marked the milestone with a specially engraved stone.
VirionHealth Raises Series A Funding from Abingworth
University of Warwick spin-out company, VirionHealth - a new biotechnology company developing novel therapeutics for respiratory viral infections, has raised £13m in Series A funding from Abingworth.